Healthy high growth potential
Results
6
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ARX | US$11.88 | -16.5% | -55.8% | US$2.4b | US$19.11 | 2.7 | 136.4% | n/a | ||
LMND | US$48.31 | -19.7% | 32.7% | US$3.8b | US$61.22 | 3.8 | 64.6% | n/a | ||
POLICYBZR | ₹1,601.50 | 4.2% | -10.1% | ₹741.0b | ₹1,943.00 | 110.6 | 30.2% | n/a | ||
NOL | AU$1.19 | 1.3% | -14.1% | AU$110.2m | AU$3.08 | 21.3 | 36.0% | n/a | ||
TWFG | US$26.80 | 2.0% | -8.8% | US$1.5b | US$27.57 | 41.6 | 38.3% | n/a | ||
OSCR | US$31.22 | 10.7% | 129.9% | US$9.4b | US$25.20 | 0.7 | 61.8% | n/a |
Page 1 of 1